High Correlation among Brain-Derived Major Protein Levels in Cerebrospinal Fluid: Implication for Amyloid-Beta and Tau Protein Changes in Alzheimer’s Disease

Kyoka Hoshi(Fukushima Medical University), Yasuhiro Hashimoto(Fukushima Medical University)

Metabolites

April 15, 2022

10.3390/metabo12040355

Cited by 5

Related Papers

Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus

|PLoS ONE|2017|44

Transferrin Biosynthesized in the Brain Is a Novel Biomarker for Alzheimer’s Disease

|Metabolites|2021|34

Brain-Derived Major Glycoproteins Are Possible Biomarkers for Altered Metabolism of Cerebrospinal Fluid in Neurological Diseases

|International Journal of Molecular Sciences|2023|1